×
> Medical Devices> Glucose Monitoring Device Market
Medical Devices MD0105 January 2020 Share

Glucose Monitoring Device Market

The Glucose Monitoring Device market is expected to grow from USD 11.66 billion in 2019 to USD 16.54 billion by 2025 at a CAGR of 6% from 2019 to 2025.

The growing incidence of diabetes and rising awareness about the self-administration of diabetes is filling the development of the market. The presentation of therapeutic gadgets that are perfect with cell phones and shrewd devices is putting forth simple access to these gadgets to an expansive number of end-clients in the global market. The incorporation glucose monitoring devices with mobile applications has facilitated the monitoring of blood glucose levels among patients. The global market is segregated on the basis of Product as Diabetes monitoring devices and insulin delivery devices. Based on Application the market is segmented in Hospitals and Personal use.

The global market report provides geographical analysis covering regions, such as North America, Europe, Asia-Pacific, and the Rest of the World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global Glucose Monitoring Device market has been segmented as below:

By Product

  • Diabetes monitoring devices
  • Insulin delivery devices

By Application

  • Hospitals
  • Personal use

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

By Company

  • Eli Lilly
  • Lupin
  • Braun
  • Takeda Pharmaceutical
  • Bayer HealthCare
  • Abbott Diabetes Care
  • Boehringer Ingelheim
  • Novo Nordisk
  • GlySens
  • Senseonics
  • Novartis
  • Omron Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • ResMed

The report covers the below scope:

  • Global market sizes from 2019 to 2025, along with CAGR for 2020-2025
  • Market size comparison for 2020 vs 2025, with actual data for 2020, estimates for 2021 and forecast from 2021 to 2025
  • Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2019
  • Estimated year - 2020
  • Projected year - 2021
  • Forecast period - 2021 to 2025

Report Scope:

The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, and others.

Why to Buy this Report:

  • Gain detailed insights on the Glucose Monitoring Device industry trends
  • Find a complete analysis of the market status
  • Identify the market opportunities and growth segments
  • Analyze competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

  • R&D and increasing technological innovations
  • Growing prevalence of diabetes on a global level

                        4.2.2 Restraints

  • Stringent rules for glucose monitoring devices
  • Standardization and unfavorable reimbursement policies

                        4.2.3 Opportunities

  • Improvements in the self-monitoring blood glucose (SMBG) devices

                        4.2.4 Challenges

            4.2 Porter's Five Force Analysis

  1. By Product

            5.1 Introduction

            5.2 Diabetes monitoring devices

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

            5.3 Insulin delivery devices

                        5.3.1 Market Overview

                        5.3.2 Market Size and Forecast

  1. By Application

            6.1 Introduction

            6.2 Hospitals

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Personal use

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

  1. By Geography

            7.1 Introduction

            7.2 North America

                        7.2.1 North America Market, By Product

                        7.2.2 North America Market, By Application

            7.3 Europe

                        7.3.1 Europe Market, By Product

                        7.3.2 Europe Market, By Application

            7.4 Asia-Pacific

                        7.4.1 Asia-Pacific Market, By Product

                        7.4.2 Asia-Pacific Market, By Application

            7.5 Rest of the World

                        7.5.1 Rest of the World Market, By Product

                        7.5.2 Rest of the World Market, By Application

  1. Competitive Insights

            8.1 Key Insights

            8.2 Company Market Share Analysis

            8.3 Strategic Outlook

                        8.3.1 Mergers & Acquisitions

                        8.3.2 New Product Development

                        8.3.3 Portfolio/Production Capacity Expansions

                        8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        8.3.5 Others

  1. Company Profiles
  • Roche
  • DexCom
  • Johnson & Johnson
  • AstraZeneca
  • Insulet
  • Sanofi
  • Merck
  • GSK
  • Nova Biomedical
  • Becton Dickinson
  • Eli Lilly
  • Lupin
  • Braun
  • Takeda Pharmaceutical
  • Bayer HealthCare
  • Abbott Diabetes Care
  • Boehringer Ingelheim
  • Novo Nordisk
  • GlySens
  • Senseonics
  • Novartis
  • Omron Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • ResMed

The global Glucose Monitoring Device market has been segmented as below:

By Product

  • Diabetes monitoring devices
  • Insulin delivery devices

By Application

  • Hospitals
  • Personal use

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

By Company

  • Eli Lilly
  • Lupin
  • Braun
  • Takeda Pharmaceutical
  • Bayer HealthCare
  • Abbott Diabetes Care
  • Boehringer Ingelheim
  • Novo Nordisk
  • GlySens
  • Senseonics
  • Novartis
  • Omron Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • ResMed

FAQ's

  • Global
  • 180Pages
  • ProMarket Research
License Options


 

Subscribe our Newsletter

Please Subscribe for exciting offers and for new reports.
Important Links
Social Media Links
Contact Us

SRR residency Kphb colony,
Near prathibha school Mig-59,
7th phase 500072,
Hyderabad.

phone call image +91 8928545557